India Coronavirus Dispatch: Bharat Biotech short of volunteers for trials

Jaipur hospital to study mutant UK strain, WHO launches a new Covid app, and five experts' take on dining inside a restaurant-news relevant to India's fight against Covid-19

Bharat Biotech ‘thousands of volunteers short’ for phase 3 trials of its vaccine candidate

Three drugmakers are seeking emergency-use authorisation for their Covid-19 vaccine candidates in India. One of them, Hyderabad-based Bharat Biotech, is still thousands of volunteers short of the target for its ongoing phase-3 trials, this report in ThePrint said.

The company has a given an indicative deadline of 31 December to the trial sites for wrapping up the recruitment of volunteers, but some of them claim it is unlikely the deadline will be met, according to the report. A company representative denied a deadline was set for volunteer recruitment,